Market Research Logo

Global Growth Hormone (GH) Market: Size, Trends & Forecasts (2018-2022)

Global Growth Hormone (GH) Market: Size, Trends & Forecasts (2018-2022)

Scope of the Report

The report titled “Global Growth Hormone (GH) Market: Size, Trends & Forecasts (2018-2022)” provides analysis of the global growth hormone market, with detailed analysis of growth hormone market in terms of its value and its subsequent segments.

The report also includes a brief analysis of the North American growth hormone market . Under competitive landscape, financial comparison of major players in the global growth hormone market on the basis of revenue and market capitalization.

Moreover, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall growth hormone market has also been forecasted for the years 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Pfizer Inc. Merck & Co, Inc., Novartis AG and Eli Lily and Company are some of the key players operating in the global growth hormone market whose company profiling is done in the report. In this segment of the report, business overview, financial overview and the business strategies of the companies are provided.

Company Coverage

Pfizer Inc.
Merck & Co,Inc.
Novartis AG
Eli Lily and Company

Regional Coverage

North America

Executive Summary

Growth hormones (GH) (also known as human growth hormones) acts as a catalyst for growth, cell reproduction, and cell regeneration in humans and also other animals. GH is vital in order to have a normal physical growth in children and adults. One of the essential applications of GH is its use in the replacement therapy in adults with GH deficiency of either childhood-onset or adult-onset. It is also used for the treatment of conditions that result into short stature emanating from conditions apart from deficiencies in GH.

The global growth hormone market can be segmented on the basis of indication, route of administration and distribution channel. On the basis of indication, the market has been sub segmented into Growth Hormone Deficiency (GHD), Turner Syndrome (TS), Idiopathic short stature (ISS) and Prader Willi Syndrome (PSS). The market is split into subcutaneous, intravenous, intramuscular and oral categories on the basis of route of administration. On the basis of distribution channel, the market is divided into hospital pharmacy, retail pharmacy, clinics and online pharmacy.

The global growth hormone market is forecasted to grow at a healthy rate during the forecast period (2018-2022). Factors supporting the market growth are increase in incidence of HIV/ AIDS, spike in occurrence of CKD, increasing number pituitary dysfunction cases and consistently rising expenditure on healthcare. Illicit distribution of growth hormones and optimization of GH therapy for an effective treatment of GHD are some of the challenges faced by the market.

Focus on improving patient experience with GH injections, long acting growth hormones in the pipeline, potential of TransCon HGH in the growth hormone market and emergence of biosimilar are some of the latest trends existing in the market.


1. Executive Summary
2. Introduction
2.1 Growth Hormone: An Overview
2.2 History of Growth Hormones
2.3 Medical Uses of Growth Hormones
2.4 Global Growth Hormone Market Segments
Table 1: Global Growth Hormone Market Segments
Table 2: Growth Hormone Market on the Basis of Indication
3. Global Market Analysis
3.1 Global Growth Hormone Market: An Analysis
3.1.1 Global Growth Hormone Market by Value
Table 3: Global Growth Hormone Market by Value; 2015-2017 (US$ Billion)
Table 4: Global Growth Hormone Market by Value; 2018-2022 (US$ Billion)
3.1.2 Global Growth Hormone Market by Region
Table 5: Global Growth Hormone Market by Region;2017 (Percentage,%)
3.2 Global Growth Hormone Market: Indication Analysis
3.2.1 Global Growth Hormone Market by Indication
Table 6: Global Growth Hormone Market by Indication;2017 (Percentage,%)
3.2.2 Global Growth Hormone Deficiency (GHD) Drugs Market by Value
Table 7: Global GHD Drugs Market by Value; 2015-2017 (US$ Billion)
Table 8: Global GHD Drugs Market by Value; 2018-2022 (US$ Billion)
3.3 Global Growth Hormone Market: Route of Administration Analysis
3.3.1 Global Growth Hormone Market by Route of Administration
Table 9: Global Growth Hormone Market by Route of Administration ; 2017 (Percentage,%)
3.3.2 Global Subcutaneous Growth Hormone Market by Value
Table 10: Global Subcutaneous Growth Hormone Market by Value; 2015-2017 (US$ Billion)
Table 11: Global Subcutaneous Growth Hormone Market by Value; 2018-2022 (US$ Billion)
3.4 Global Growth Hormone Market: Distribution Channel Analysis
3.4.1 Global Growth Hormone Market by Distribution Channel
Table 12: Global Growth Hormone Market by Distribution Channel; 2017 (Percentage
3.4.2 Global Hospital Pharmacy Market by Value
Table 13: Global Hospital Pharmacy Market by Value; 2015-2017 (US$ Billion)
Table 14: Global Hospital Pharmacy Market by Value; 2018-2022 (US$ Billion)
3.5 Global Growth Hormone Market: Drug Type Analysis
3.5.1 Global Growth Hormone Market by Drug Type
Table 15: Global Growth Hormone Market by Drug Type; 2017 (Percentage,%)
Table 16: Global Growth Hormone Market by Drug Type; 2022 (Percentage,%)
3.6 Global Growth Hormone Market: LAGH Drugs Analysis
3.6.1 Global LAGH Drugs Market by Value
Table 17: Global LAGH Drugs Market by Value; 2021-2025 (US$ Billion)
3.6.2 Global LAGH Market by Brands
Table 18: Global LAGH Market by Brands; 2022 (Percentage,%)
3.6.3 Global TransCon HGH Market by Value
Table 19: Global TransCon HGH Market by Value; 2021-2025 (US$ Million)
4. Regional Analysis
4.1 North America Growth Hormone Market: An Analysis
4.1.1 North America Growth Hormone Market by Value
Table 20: North America Growth Hormone Market by Value; 2016-2017 (US$ Billion)
Table 21: North America Growth Hormone Market by Value; 2018-2022 (US$ Billion)
4.1.2 North America Growth Hormone Market by Countries
Table 22: North America Growth Hormone Market by Countries; 2017 (Percentage,%)
4.2 The US Growth Hormone Market: An Analysis
4.2.1 The US Growth Hormone Market by Value
Table 23: The US Growth Hormone Market by Value; 2015-2017 (US$ Billion)
Table 24: The US Growth Hormone Market by Value; 2018-2022 (US$ Billion)
4.2.2 The US Growth Hormone Market by Patient Type
Table 25: The US Growth Hormone Market by Patient Type; 2017 (Percentage,%)
4.2.3 The US Pediatric Growth Hormone Market by Value
Table 26: The US Pediatric Growth Hormone Market by Value; 2017-2022 (US$ Millio
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Incidence of HIV/AIDS
Table 27: People with HIV/ AIDS (All Ages); 2010-2017 (Million)
5.1.2 Rise in Number of Pituitary Dysfunction Cases
5.1.3 Spike in Occurrence of Chronic Kidney Disease (CKD)
5.1.4 Ascending Health Care Spending
Table 28: Global Health Care Spending; 2015-2020 (US$ Trillion)
5.2 Challenges
5.2.1 Illicit Distribution of Human Growth Hormone
5.2.2 Barriers in Obtaining Perfect Results in Treating GHD
5.3 Market Trends
5.3.1 Focus on Improving Experience of Patients with GH Injections
5.3.2 Long Acting Formulations in Development
Table 29: Long Acting Growth Hormones undergoing trials and pre clinical studies
5.3.3 Potential of TransCon HGH in the Growth Hormone Market
5.3.4 Emergence of Biosimilar Growth Hormones
6. Competitive Landscape
6.1 Global Growth Hormone Market: Players Comparison
Table 30: Global Growth Hormone Market Financial Comparison; 2017
7. Company Profiles
7.1 Pfizer, Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
Table 31: Pfizer, Inc. Revenue; 2013-2017 (US$ Billion)
Table 32: Pfizer, Inc. Revenue by Segments; 2017 (Percentage, %)
Table 33: Pfizer, Inc. Revenue by Region; 2017 (Percentage, %)
7.1.3 Business Strategy
7.2 Merck & Co., Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
Table 34: Merck & Co. Inc. Sales; 2013-2017 (US$ Billion)
Table 35: Merck & Co. Inc. Sales by Segment; 2017 (Percentage, %)
Table 36: Merck & Co. Inc. Sales by Region; 2017 (Percentage, %)
7.2.3 Business Strategy
7.3 Novartis AG
7.3.1 Business Overview
Table 37: Novartis AG Business Segments
7.3.2 Financial Overview
Table 38: Novartis Net Sales; 2013-2017 (US$ Billion)
Table 39: Novartis Sales by Segment; 2017 (Percentage, %)
Table 40: Novartis Sales by Region; 2017 (Percentage, %)
7.3.3 Business Strategy
7.4 Eli Lily and Company
7.4.1 Business Overview
7.4.2 Financial Overview
Table 41: Eli Lily and Company Revenues; 2013-2017 (US$ Billion)
Table 42: Eli Lily and Company Revenues by Segments; 2017 (Percentage,%)
7.4.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report